The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Medical Devices
Sinocare Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.10% CNY24.63
America/New_York / 6 mai 2024 @ 00:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 13 641 mill |
| EPS: | 0.550 |
| P/E: | 44.78 |
| Earnings Date: | May 21, 2024 |
| SharesOutstanding: | 553.84 mill |
| Avg Daily Volume: | 5.14 mill |
| RATING 2024-05-06 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.25x |
| Company: PE 44.78 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.10x |
| Company: PE 44.78 | industry: PE 40.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY50.89 (106.61%) CNY26.26 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 23.80 - 25.46 ( +/- 3.35%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY24.63 (3.10% ) |
| Volume | 3.14 mill |
| Avg. Vol. | 5.14 mill |
| % of Avg. Vol | 61.17 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 300298.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
300298.SZ
Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.